Maja Mockenhaupt

Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal Necrolysis

Jean‐Claude Roujeau, Judith P. Kelly, Luigi Naldi et al. · New England Journal of Medicine · 1995 · 1.4K citations

Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emphasis on Recently Marketed Drugs. The EuroSCAR-Study

Maja Mockenhaupt, Cécile Viboud, Ariane Dunant et al. · Journal of Investigative Dermatology · 2007 · 978 citations · Full text

Drug Safety, Toxic Epidermal Necrolysis, Recently Marketed Drugs +10

Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study

Sylvia H. Kardaun, Peggy Sekula, L. Valeyrie‐Allanore et al. · British Journal of Dermatology · 2013 · 936 citations

ALDEN, an Algorithm for Assessment of Drug Causality in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Comparison With Case–Control Analysis

B. Sassolas, Cynthia Haddad, Maja Mockenhaupt et al. · Clinical Pharmacology & Therapeutics · 2010 · 707 citations

Correlations Between Clinical Patterns and Causes of Erythema Multiforme Majus, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis

Ariane Auquier-Dunant, Maja Mockenhaupt, Luigi Naldi et al. · Archives of Dermatology · 2002 · 615 citations